236 related articles for article (PubMed ID: 25736530)
21. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
Hirakawa M; Nagai Y; Inamine M; Kamiyama K; Ogawa K; Toita T; Murayama S; Aoki Y
Gynecol Oncol; 2008 Jan; 108(1):126-9. PubMed ID: 17936344
[TBL] [Abstract][Full Text] [Related]
22. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer.
Katanyoo K; Sanguanrungsirikul S; Manusirivithaya S
Gynecol Oncol; 2012 May; 125(2):292-6. PubMed ID: 22293041
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of two different chemotherapy regimens for concurrent chemoradiotherapy in stage Ib2 to IVa squamous cell carcinoma of the uterine cervix].
Li XF; Li YH; Gao YN; Li CL; Yue HZ; Xu G; Li DM; Su X
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):763-7. PubMed ID: 24406134
[TBL] [Abstract][Full Text] [Related]
24. Profiling protein markers associated with the sensitivity to concurrent chemoradiotherapy in human cervical carcinoma.
Zhu H; Pei HP; Zeng S; Chen J; Shen LF; Zhong MZ; Yao RJ; Shen H
J Proteome Res; 2009 Aug; 8(8):3969-76. PubMed ID: 19507834
[TBL] [Abstract][Full Text] [Related]
25. Neutrophils promote tumor resistance to radiation therapy.
Wisdom AJ; Hong CS; Lin AJ; Xiang Y; Cooper DE; Zhang J; Xu ES; Kuo HC; Mowery YM; Carpenter DJ; Kadakia KT; Himes JE; Luo L; Ma Y; Williams N; Cardona DM; Haldar M; Diao Y; Markovina S; Schwarz JK; Kirsch DG
Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18584-18589. PubMed ID: 31462499
[TBL] [Abstract][Full Text] [Related]
26. Clinical implications of elevated pretreatment carcinoembryonic antigen in patients with advanced squamous cell carcinoma of the uterine cervix.
Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Yang SN; Lin FJ
Tumour Biol; 2008; 29(4):255-61. PubMed ID: 18781097
[TBL] [Abstract][Full Text] [Related]
27. Prognostic nutritional index and neutrophil-lymphocyte ratio predict toxicities and prognosis in patients with cervical cancer treated with curative radiochemotherapy.
Chen JL; Huang CY; Shih IL; Liou YM; Tai YJ; Chiang YC; Kuo CY
J Formos Med Assoc; 2024 Jun; 123(6):671-678. PubMed ID: 37996325
[TBL] [Abstract][Full Text] [Related]
28. Clinical Significance of the Neutrophil-to-Lymphocyte Ratio in Endocrine Therapy for Stage IV Breast Cancer.
Iimori N; Kashiwagi S; Asano Y; Goto W; Takada K; Takahashi K; Hatano T; Takashima T; Tomita S; Motomura H; Hirakawa K; Ohira M
In Vivo; 2018; 32(3):669-675. PubMed ID: 29695577
[TBL] [Abstract][Full Text] [Related]
29. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy.
Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Lee SP; Hong JH
Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):420-7. PubMed ID: 22365621
[TBL] [Abstract][Full Text] [Related]
30. Outcomes and toxicities for the treatment of stage IVB cervical cancer.
Hwang JH; Lim MC; Seo SS; Kang S; Park SY; Kim JY
Arch Gynecol Obstet; 2012 Jun; 285(6):1685-93. PubMed ID: 22173823
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of haematologic parameter changes during treatment in cervical cancer patients treated with definitive chemoradiotherapy.
Yildirim BA; Guler OC; Kose F; Onal C
J Obstet Gynaecol; 2019 Jul; 39(5):695-701. PubMed ID: 31023114
[TBL] [Abstract][Full Text] [Related]
32. Nomograms for predicting prognostic value of combined neutrophil-to-lymphocyte ratio and SCC-Ag in locally advanced cervical cancer.
Jin L; Cao F; Zhang Y; Dang Y; Wang F
Transl Cancer Res; 2024 Mar; 13(3):1323-1335. PubMed ID: 38617514
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of cyclooxygenase-2 is associated with a poor prognosis in patients with squamous cell carcinoma of the uterine cervix treated with radiation and concurrent chemotherapy.
Kim YB; Kim GE; Cho NH; Pyo HR; Shim SJ; Chang SK; Park HC; Suh CO; Park TK; Kim BS
Cancer; 2002 Aug; 95(3):531-9. PubMed ID: 12209745
[TBL] [Abstract][Full Text] [Related]
34. Retrospective Analysis of Concurrent Chemoradiation with Triweekly Cisplatin plus 5-Fluorouracil Versus Weekly Cisplatin in Cervical Cancer.
Sonoda K; Yahata H; Ichinoe A; Okugawa K; Kaneki E; Kawano Y; Kenjo H; Ohgami T; Yagi H; Ohga S; Asai K; Nakamura K; Honda H; Kato K
Anticancer Res; 2015 Jun; 35(6):3447-54. PubMed ID: 26026109
[TBL] [Abstract][Full Text] [Related]
35. Neutrophil-lymphocyte ratio predicts pathologic tumor response and survival after preoperative chemoradiation for rectal cancer.
Kim IY; You SH; Kim YW
BMC Surg; 2014 Nov; 14():94. PubMed ID: 25406793
[TBL] [Abstract][Full Text] [Related]
36. Effect of concurrent intra-arterial infusion of platinum drugs for patients with stage III or IV uterine cervical cancer treated with radical radiation therapy.
Onishi H; Yamaguchi M; Kuriyama K; Tsukamoto T; Ishigame K; Ichikawa T; Aoki S; Yoshikawa T; Araki T; Nambu A; Araki T; Hashi A; Yasumizu T; Hoshi K; Ito H
Cancer J Sci Am; 2000; 6(1):40-5. PubMed ID: 10696738
[TBL] [Abstract][Full Text] [Related]
37. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
38. Squamous cell carcinoma antigen in patients with locally advanced cervical carcinoma undergoing preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.
Ferrandina G; Macchia G; Legge F; Deodato F; Forni F; Digesù C; Carone V; Morganti AG; Scambia G
Oncology; 2008; 74(1-2):42-9. PubMed ID: 18544959
[TBL] [Abstract][Full Text] [Related]
39. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel.
Buttigliero C; Pisano C; Tucci M; Vignani F; Bertaglia V; Iaconis D; Guglielmini P; Numico G; Scagliotti GV; Di Maio M
Acta Oncol; 2017 Apr; 56(4):555-562. PubMed ID: 28068151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
